We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Digilab BioVisioN Continues Biomarker Cooperation with a Top 10 Pharmaceutical Company
News

Digilab BioVisioN Continues Biomarker Cooperation with a Top 10 Pharmaceutical Company

Digilab BioVisioN Continues Biomarker Cooperation with a Top 10 Pharmaceutical Company
News

Digilab BioVisioN Continues Biomarker Cooperation with a Top 10 Pharmaceutical Company

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Digilab BioVisioN Continues Biomarker Cooperation with a Top 10 Pharmaceutical Company"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Digilab BioVisioN and Novartis will continue and expand their cooperation in the field of biomarker discovery in drug treatment studies.

Digilab BioVisioN announced the closure of a new agreement applying their Peptidomics® technology in the quantitative characterization of the peptides in biological samples (the peptidome) with the aim to discover potential biomarkers.

Apart from a research payment, Digilab BioVisioN will receive milestone payments and royalties as success payments. The contract continues a successful cooperation of both companies dating from 2004.

Advertisement